Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Skov J, Dejgaard A, Frkir J, Holst JJ, Jonassen T, Rittig S, et al
Supplementation with glutathione has been met with little success as the bioavailability of glutathione is low due its transient transport throughout the cellular network
Afamelanotide is FDA- (2019) and EMA-approved (2014) for EPP
Research and development continues to be the companys primary focus, representing 76% of operating expenses, while sales and marketing (7%) and general and administrative expenses (17%) make up the remainder
Not consenting or withdrawing consent may adversely affect certain features and functions.
US$ 26.77
US$ 26.59
US$ 25.94
US$ 20.67
US$ 21.14
